Leishmaniasis Visceral East African

East African visceral leishmaniasis (EVV) is an infectious disease caused by the parasite Leishmania donovani subspecies archibaldi. It is common in the savannah region of East Africa, home to more than 20 million people.

PVV is characterized by the formation of skin nodules on exposed areas of the body, which can ulcerate and lead to the development of serious complications such as cellulitis and abscess. However, the most dangerous is damage to internal organs, including the liver, spleen, lymph nodes and lungs.

The causative agent of VPV is transmitted through the bite of a mosquito. The incubation period of the disease ranges from several weeks to several months. Treatment of PVT includes the use of antiprotozoal drugs such as mefloquine or amphotericin B.

Due to the high prevalence of VVV in the East African region, measures must be taken to prevent and control this disease. One such measure is to control the use of insecticides and other chemicals that may contribute to the spread of mosquitoes that carry Leishmania. It is also important to regularly diagnose and treat all cases of PVT to prevent complications from developing and reduce the risk of spreading the disease.

Leishmaniasis is a group of vector-borne diseases of humans and animals of a zoonotic nature, caused by obligate intracellular parasites. Currently, more than 30 species of Leishmania are known, belonging to different genera and families among animals and fungi, widespread throughout the globe, but are the subject of special attention by helminthologists and parasitologists